Articles

There is good news for income-oriented investors — or anybody who owns any of the so-called Magnificent Seven tech stocks that have powered much of the S&P 500’s gains over the past year.

CymaBay Therapeutics shares jumped 24% early Monday after Gilead Sciences reached a $4.3 billion deal to acquire the liver-drug developer.

Maybe we don’t need to keep having our kids sell cookies and candy to the next-door neighbor.

Shares of Big Lots Inc. were in danger of having their worst day in four years on Monday, after Loop Capital warned investors away from the discount home essentials retailer, citing a “precarious” financial situation and loss of relevance with consumers.

The stock surged on trading volume of 72.63 million shares Friday, well above its 65-day trading volume of 1.26 million shares, and was halted for volatility during the session.

AbbVie Inc.’s stock fell 0.5% early Monday, after the biotech lowered its first-quarter guidance to reflect the dilutive impact of its closure of the acquisition of ImmunoGen.

Oil prices pull back to begin the week.

The most heavily shorted stocks have underperformed in 2024 compared to rivals, in a turnaround compared to 2023

The yield on the 2-year German bund fell Monday as a European Central Bank official raised the prospect of a fairly imminent rate cut.

Tod’s stock jumped 17% in Milan following a takeover bid announced Sunday by U.S.-based private equity group L Catterton.

Post Content

At inflection points the momentum can suddenly shift.